← Back to Clinical Trials
Recruiting NCT05804461

NCT05804461 Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05804461
Status Recruiting
Phase
Sponsor University of Puerto Rico
Condition HIV Prevention
Study Type INTERVENTIONAL
Enrollment 182 participants
Start Date 2023-09-01
Primary Completion 2027-05-31

Eligibility & Interventions

Sex Male only
Min Age 21 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Motivational Interviewing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 182 participants in total. It began in 2023-09-01 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To develop, assess and compare the effectiveness of a Motivational Interviewing Intervention for increasing Pre-Exposure Prophylaxis (PrEP) uptake among Latino eligible men in Puerto Rico.

Eligibility Criteria

Latino MSM group - Inclusion Criteria: * Biological male * Age 21 or older * Self-reported HIV negative or unknown status * Not using PrEP (participants who have discontinued PrEP use can participate in the study), Spanish fluency (ability to write and read in Spanish) * Presenting at least one of the eligibility criteria for PrEP as established by the CDC (including men who have had an infection (STI) in the past 6 months, HIV positive sexual partner) * Access to a portable technology device (e.g., phone, tablet, laptop) or desktop computer access to internet connection Exclusion Criteria: * HIV positive individual * Evidence of being under the effects of alcohol or drugs * Indication of unstable or serious psychiatric symptoms * Evidence of major cognitive impairment * Inability to speak and read in Spanish Healthcare Providers group - Inclusion Criteria: * Age 21 or older * Providing PrEP related health services at time of enrollment (e.g., case management, clinical services) * Spanish fluency (ability to write and read in Spanish) Exclusion Criteria: * Evidence of being under the effects of alcohol or drugs * Indication of unstable or serious psychiatric symptoms * Evidence of major cognitive impairment * Inability to speak and read in Spanish

Frequently Asked Questions

Who can join the NCT05804461 clinical trial?

This trial is open to male participants only, aged 21 Years or older, up to 99 Years, studying HIV Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05804461 currently recruiting?

Yes, NCT05804461 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Puerto Rico to inquire about joining.

Where is the NCT05804461 trial being conducted?

This trial is being conducted at San Juan, Puerto Rico.

Who is sponsoring the NCT05804461 clinical trial?

NCT05804461 is sponsored by University of Puerto Rico. The trial plans to enroll 182 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology